VERU INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
VERU INC. (VERU) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 119.25 thousand shares for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-17.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2025-12-17
- VERU INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 119.25K shares, a 91.30% decline from fiscal 2024.
- VERU INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 1.37M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|
| 2025-09-30 | 119.25K shares 10-K · filed 2025-12-17 |
| 2024-09-30 | 1.37M shares 10-K · filed 2024-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |